Iowa Woman Files NuvaRing Pulmonary Embolism Lawsuit

Hascall alleges in the NuvaRing lawsuit that she chose the contraceptive device based on the allegedly aggressive and misleading advertising of the defendant companies. On September 29, 2011, Hascall began experiencing pain in the right side of her chest, which was accompanied by shortness of breath. A week and a half later on October 2, the plaintiff was submitted to a hospital due to these continuing symptoms. Upon immediate inspection, the hospital discovered she was suffering from a segmental right lobe pulmonary embolism.

Hascall was immediately taken into surgery and given five doses of Warfarin, an anti-coagulant drug used to treat and prevent blood clots. To this day, Hascall requires regular follow-up care. According to her lawsuit, Hascall suffered multiple NuvaRing blood clot side effects, including deep vein thrombosis (DVT) and a pulmonary embolism (PE). Allegedly, each of the defendant companies knew of these possible NuvaRing side effects, but failed to include them on the warning label, nor did they make any effort to warn the plaintiff.

At the time she received the NuvaRing, neither the plaintiff nor her physician had any awareness of the possible side effects that could have occurred from using the product, the lawsuit claims. Had she known, Hascall she never would have opted for the NuvaRing. Hascall alleges that each of the companies are liable for being in direct business with each other, therefore protecting the same interests, and had the same obligations to prevent injury to her and other patients who used this birth control product.

Hascall is suing Organon, Merck, and the other defendant companies for alleged negligence and for allegedly distributing, selling, and marketing a dangerous product. Other charges include false advertising, misrepresenting a product, and concealing information.

The NuvaRing lawsuit is Heather Hascall v. Organon USA Inc., et al., Case 4:13-cv-00414-JEG-TJS, in the United States District Court of Southern Iowa.

Overview of NuvaRing Complications

The NuvaRing is a vaginal birth control ring that is directly placed into the patient, and needs to be replaced monthly as the description says. The product works by releasing Etonogestrel, a synthetic third-generation progestin, into the body, which prevents pregnancy. While highly regarded as a success, it has been recently discovered that NuvaRing may not have undergone pre-market testing before it was released, and that this product may cause some adverse effects not listed on the drug’s label.

The NuvaRing side effects that have been reported in numerous adverse injury reports include:

• deep vein thrombosis (DVT)
• pulmonary embolism (PE)
• stroke
• heart attack
• death

None of these potential NuvaRing side effects were mentioned on the drug’s warning label. Allegedly, the defendant companies made untrue statements in their advertisements and made untrue and misleading material to exaggerate the product’s efficiency, according to numerous product liability lawsuits. Additionally, the lawsuit allege that the risks of NuvaRing blood clots were not adequately explained in any of the advertisements, and that defendants represented the product being overtly superior compared to other birth control products.

Obtain a Free NuvaRing Lawsuit Evaluation

If you believe that you or a loved one has been the victim of a NuvaRing injury, you have legal options. Please visit the NuvaRing Birth Control Class Action Lawsuit Settlement & Investigation. There, you can submit your claim for a free legal review and if it qualifies for legal action, a seasoned NuvaRing lawyer will contact you for a free, no-obligation consultation. You will be guided through the litigation process at no out-of-pocket expenses or hidden fees. The NuvaRing lawyers working this investigation do not get paid until you do.